Skip to main content
Clinical Trials/NCT01726218
NCT01726218
Completed
Not Applicable

Enhancing Stroke Recovery Through Cortical Stimulation: The Role of the Ipsilateral Motor Cortex in Executing Movements With Increasing Demand on Precision

Cathrin Buetefisch1 site in 1 country20 target enrollmentMay 2011
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Cathrin Buetefisch
Enrollment
20
Locations
1
Primary Endpoint
Define key parameters that contribute to contralesional M1 reorganization following stroke
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

It is well known that the motor area of one hemisphere of the brain (motor cortex) controls the movement of the opposite of the body. However, it is not clear whether as the movement becomes more complicated, the motor cortex of both hemispheres of the brain are involved. Currently the role of the motor cortex on the same side of the body (referred to as ipsilateral motor cortex) in hand performance remains controversial. The investigators demonstrated previously in healthy subjects that transiently lowering the activity of ipsilateral motor cortex improved the performance of the opposite hand. What is not know are the mechanisms involved in these changes of behavior. Transcranial magnetic stimulation (TMS) is a device that allows the non- invasive stimulation of the brain. When brain is stimulated repetitively at a very low rate and low intensity for about 15 minutes, the stimulated brain area becomes less active. This effect lasts 10 minutes and is called a "transient artificial lesion" as it mimicks the effects of transiently interfering with the function of the stimulated brain area. In the present study the investigators will conduct experiments using repetitive TMS to downregulate the activity of the motor area as in previous experiments and measures its effect on activity of motor cortex of both hemispheres. The investigators will study healthy subjects. It would be important to understand the effects in more detail for the design of treatment strategies in patients after stroke, which will be a topic of future studies.

Registry
clinicaltrials.gov
Start Date
May 2011
End Date
March 26, 2015
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Cathrin Buetefisch
Responsible Party
Sponsor Investigator
Principal Investigator

Cathrin Buetefisch

Dr Cathrin Buetefisch, M.D., PhD

Emory University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Define key parameters that contribute to contralesional M1 reorganization following stroke

Time Frame: Up to six months post-stroke

Study Sites (1)

Loading locations...

Similar Trials